10x Genomics Reports Second Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
10x Genomics (TXG) Tops Q2 EPS by 16c
August 4, 2021 4:59 PM EDT10x Genomics (NASDAQ: TXG) reported Q2 EPS of ($0.10), $0.16 better than the analyst estimate of ($0.26). Revenue for the quarter came in at $115.8 million versus the consensus estimate of $112.85 million.
GUIDANCE:
10x Genomics sees FY2021 revenue of $480-500 million.
For earnings history and earnings-related data on 10x Genomics (TXG) click here.
... More


